Clinical Trials in Chicago

Showing 6181-6200 of 20,493 trials

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

NCT03400150

The BioProtect Balloon Implant™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the balloon to reduce the radiation dose delivered to the anterior rectum. The balloon composed of a biodegradable material that maintains that space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.

Prostate Cancer

BioProtect222 participantsStarted Jan 2018

Apple Valley, California, United States • Irvine, California, United States • Daytona Beach, Florida, United States +13 more locations

COMPLETEDPhase 22.2 miles

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

NCT04714320

The purpose of this study was to evaluate the effect of IONIS-AGT-LRx compared to placebo on seated automated office systolic blood pressure (SBP) from baseline to Study Day 85 in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications and to evaluate the effect of IONIS-AGT-LRx on ambulatory blood pressure, seated automated office SBP, seated automated office diastolic blood pressure (DBP), and plasma angiotensinogen (AGT) at each scheduled visit in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications.

Hypertension

Ionis Pharmaceuticals, Inc.160 participantsStarted Apr 2021

Anniston, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +47 more locations

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

Find Trials by Condition in Chicago

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

Neuroblastoma Precision Trial

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

INFINITY™Total Ankle Replacement Follow-up

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

MCT for the Harvard/UCSF ROBIN Center